An Overview of Clinical Trials in the Treatment of Resectable Hepatocellular Carcinoma
- 3 November 2022
- journal article
- research article
- Published by Elsevier in Surgical Oncology Clinics of North America
- Vol. 32 (1) , 101-117
Abstract
No abstract availableKeywords
Funding Information
- National Center on Minority Health and Health Disparities (1R01MD012565-01)
This publication has 76 references indexed in Scilit:
- Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled TrialPLOS ONE, 2013
- Infrahepatic Inferior Vena Cava Clamping for Reduction of Central Venous Pressure and Blood Loss During Hepatic ResectionAnnals of Surgery, 2011
- A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2009
- A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular CarcinomaAnnals of Surgery, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- A Randomized, Controlled Trial of Postoperative Adjuvant Interferon Therapy After Resection of Hepatocellular CarcinomaAnnals of Surgery, 2007
- Anterior Approach Versus Conventional Approach Right Hepatic Resection for Large Hepatocellular CarcinomaAnnals of Surgery, 2006
- Bleeding during hepatectomy can be reduced by clamping the inferior vena cava below the liverSurgery, 2004
- Liver Hanging Maneuver: A Safe Approach To Right Hepatectomy Without Liver MobilizationJournal of the American College of Surgeons, 2001
- Hepatic function and liver resectionJournal of Gastroenterology and Hepatology, 1990